武(wu)漢凱德維斯生(sheng)物(wu)技(ji)術(shu)(shu)有限(xian)公(gong)(gong)司成(cheng)(cheng)立于(yu)2018年,以華中(zhong)(zhong)科(ke)技(ji)大(da)學(xue)(xue)同濟醫(yi)學(xue)(xue)院附屬(shu)同濟醫(yi)院婦(fu)產(chan)科(ke)系主(zhu)任、中(zhong)(zhong)國(guo)(guo)工(gong)程院院士馬丁為核心(xin),擁有一支在國(guo)(guo)際商業(ye)拓展(zhan)及藥物(wu)推(tui)廣(guang)開(kai)(kai)發(fa)領域具有豐(feng)富成(cheng)(cheng)功經(jing)驗的(de)高(gao)素質人才和管理人才組成(cheng)(cheng)的(de)創(chuang)業(ye)團隊,具備強大(da)的(de)臨床轉化(hua)研(yan)(yan)究開(kai)(kai)發(fa)能力和經(jing)驗。公(gong)(gong)司整合湖北省一流(liu)的(de)科(ke)研(yan)(yan)平臺(腫瘤侵襲與轉移教育部重點(dian)實(shi)(shi)驗室(shi)(shi)和病毒學(xue)(xue)國(guo)(guo)家重點(dian)實(shi)(shi)驗室(shi)(shi)),在光(guang)谷生(sheng)物(wu)城征地近30畝,建設“婦(fu)科(ke)腫瘤診(zhen)療(liao)創(chuang)新成(cheng)(cheng)果轉化(hua)中(zhong)(zhong)心(xin)項目”,致(zhi)力于(yu)打造國(guo)(guo)內(nei)領先(xian)、國(guo)(guo)際一流(liu)的(de)婦(fu)科(ke)腫瘤診(zhen)療(liao)創(chuang)新產(chan)品研(yan)(yan)發(fa)中(zhong)(zhong)心(xin)及配套生(sheng)產(chan)基地。公(gong)(gong)司圍繞診(zhen)斷(duan)(duan)試劑,生(sheng)物(wu)創(chuang)新藥及技(ji)術(shu)(shu)開(kai)(kai)發(fa)與服(fu)務三個方面開(kai)(kai)展(zhan)業(ye)務,覆(fu)蓋早期預防、早期篩(shai)查(cha)、早期診(zhen)斷(duan)(duan)、術(shu)(shu)中(zhong)(zhong)輔助診(zhen)斷(duan)(duan)和治療(liao)五大(da)婦(fu)科(ke)疾病全(quan)環節。